March 15, 2018

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on legislation, the “Patient Right to Know Drug Prices Act” and the “Know the Lowest Price Act,” introduced today in the Senate:

“We support the patient always paying the lowest cost at the pharmacy counter, whether it’s the cash price or the copay. This is standard industry practice in both Medicare and the commercial sector.

We would oppose contracting that prohibits drugstores from sharing with patients the cash price they charge for each drug.  These rates are set entirely at the discretion of each pharmacy and can vary significantly from drugstore to drugstore.

Fortunately, to the degree this issue was ever rooted in more than anecdotal information, it has been addressed in the marketplace.”